A large-scale immuno-epidemiological simulation of influenza A epidemics

BMC Public Health

Volumn 14, Issue 1, 2014, Pages

  Lukens, Sarah ^a,f   Depasse, Jay ^b   Rosenfeld, Roni ^c   Ghedin, Elodie ^d   Mochan, Ericka ^d   Brown, Shawn T ^b   Grefenstette, John ^e   Burke, Donald S ^e   Swigon, David ^a   Clermont, Gilles ^d  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b CARNEGIE MELLON UNIVERSITY   (United States)

^c Carnegie Mellon University   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; CHILD; EPIDEMIC; HUMAN; IMMUNOLOGY; INFLUENZA VIRUS A H1N1; INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; MIDDLE AGED; PRESCHOOL CHILD; THEORETICAL MODEL; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; EPIDEMICS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MIDDLE AGED; MODELS, THEORETICAL; PENNSYLVANIA; YOUNG ADULT;

EID: 84907983517     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-14-1019     Document Type: Article

References (74)

1. Towards multiscale modeling of influenza infection. Murillo LN, Murillo MS, Perelson AS, J Theor Biol 2013 332 267 290 23608630
2. Keeling MJ, Rohani P, Modeling infectious diseases in humans and animals New Jersey: Princeton University Press 2008
3. Modelling disease outbreaks in realistic urban social networks. Eubank S, Guclu H, Kumar VA, Marathe MV, Srinivasan A, Toroczkai Z, Wang N, Nature 2004 429 6988 180 184 10.1038/nature02541 15141212
4. FRED (A Framework for Reconstructing Epidemic Dynamics): an open-source software system for modeling infectious diseases and control strategies using census-based populations. Grefenstette JJ, Brown ST, Rosenfeld R, DePasse J, Stone NT, Cooley PC, Wheaton WD, Fyshe A, Galloway DD, Sriram A, Guclu H, Abraham T, Burke DS, BMC Public Health 2013 13 940 10.1186/1471-2458-13-940 24103508
5. Modeling targeted layered containment of an influenza pandemic in the United States. Halloran ME, Ferguson NM, Eubank S, Longini IM, Cummings DA, Lewis B, Xu S, Fraser C, Vullikanti A, Germann TC, Wagener D, Beckman R, Kadau K, Barrett C, Macken CA, Burke DS, Cooley P, Proc Natl Acad Sci 2008 105 12 4639 4644 10.1073/pnas.0706849105 18332436
6. Containing pandemic influenza at the source. Longini I, Nizam A, Xu S, Ungchusak K, Hanshaoworakul W, Cummings D, Halloran M, Science 2005 309 5737 1083 1087 10.1126/science.1115717 16079251
7. Simulating school closure strategies to mitigate an influenza epidemic. Lee B, Brown S, Cooley P, Potter M, Wheaton W, Voorhees R, Stebbins S, Grefenstette J, Zimmer S, Zimmerman R, Assi T-M, Bailey RR, Wagener DK, Burke DS, J Public Health Manag Pract: JPHMP 2010 16 3 252 10.1097/PHH.0b013e3181ce594e
8. Would school closure for the 2009 H1N1 influenza epidemic have been worth the cost?: A computational simulation of Pennsylvania. Brown ST, Tai JH, Bailey RR, Cooley PC, Wheaton WD, Potter MA, Voorhees RE, LeJeune M, Grefenstette JJ, Burke DS, McGlone SM, Lee BY, BMC Public Health 2011 11 353 10.1186/1471-2458-11-353 21599920
9. The role of subway travel in an influenza epidemic: A New York City simulation. Cooley P, Brown S, Cajka J, Chasteen B, Ganapathi L, Grefenstette J, Hollingsworth C, Lee B, Levine B, Wheaton WD, Wagener DK, J Urban Health 2011 88 5 982 995 10.1007/s11524-011-9603-4 21826584
10. Policies to reduce influenza in the workplace: impact assessments using an agent-based model. Kumar S, Grefenstette J, Galloway D, Albert S, Burke D, Am J Public Health 2013 103 8 1406 1411 10.2105/AJPH.2013.301269 23763426
11. A computer simulation of vaccine prioritization, allocation, and rationing during the 2009 H1N1 influenza pandemic. Lee B, Brown S, Korch G, Cooley P, Zimmerman R, Wheaton W, Zimmer S, Grefenstette J, Bailey R, Assi T-M, Burke DS, Vaccine 2010 28 31 4875 4879 10.1016/j.vaccine.2010.05.002 20483192
12. The benefits to all of ensuring equal and timely access to influenza vaccines in poor communities. Lee B, Brown S, Bailey R, Zimmerman R, Potter M, McGlone S, Cooley P, Grefenstette J, Zimmer S, Wheaton W, Quinn SC, Voorhees RE, Burke DS, Health Aff 2011 30 6 1141 1150 10.1377/hlthaff.2010.0778
13. Immunoepidemiology-bridging the gap between immunology and epidemiology. Hellriegel B, Trends Parasitol 2001 17 2 102 106 10.1016/S1471-4922(00)01767-0 11227997
14. Modeling host-parasite coevolution: a nested approach based on mechanistic models. Gilchrist MA, Sasaki A, J Theor Biol 2002 218 3 289 308 10.1006/jtbi.2002.3076 12381431
15. Linking within-and between-host dynamics in the evolutionary epidemiology of infectious diseases. Mideo N, Alizon S, Day T, Trends Ecol Evol 2008 23 9 511 517 10.1016/j.tree.2008.05.009 18657880
16. Epidemic dynamics and host immune response: a nested approach. Gandolfi A, Pugliese A, Sinisgalli C, J Math Biol 2014 1 1 37
17. Persistence of viral infections on the population level explained by an immunoepidemiological model. Kostova T, Math Biosci 2007 206 2 309 319 10.1016/j.mbs.2005.08.003 16214182
18. Implications of vaccination and waning immunity. Heffernan J, Keeling MJ, Proc R Soc B: Biol Sci 2009 276 1664 2071 2080 10.1098/rspb.2009.0057
19. An epidemic model structured by host immunity. Martcheva M, Pilyugin SS, J Biol Syst 2006 14 02 185 203 10.1142/S0218339006001787
20. Evolution of virulence: interdependence, constraints, and selection using nested models. Gilchrist MA, Coombs D, Theor Popul Biol 2006 69 2 145 153 10.1016/j.tpb.2005.07.002 16198387
21. Meeting summary of the workshop 'approaches to better understand human influenza transmission. Snider D, Bridges C, Weissman D, Approaches to better understand human influenza transmission. Centers for Disease Control and Prevention (United States of America). 4-5 November 2010; Atlanta, Georgia 2010 [ http://www.cdc.gov/influenzatransmissionworkshop2010/ ]
22. Transmission of influenza: implications for control in health care settings. Weinstein RA, Bridges CB, Kuehnert MJ, Hall CB, Clin Infect Dis 2003 37 8 1094 1101 10.1086/378292 14523774
23. Local and systemic cytokine responses during experimental human influenze A virus infection. Hayden F, Fritz R, Lobo M, Alvord W, Strober W, Straus S, J Clin Invest 1998 101 643 649 10.1172/JCI1355 9449698
24. Nasal cytokine and chemokine responses in experimental influenza A virus infection: results of a placebo-controlled trial of intravenous zanamivir treatment. Fritz R, Hayden F, Calfee D, J Infect Dis 1999 180 586 593 10.1086/314938 10438343
25. Inflammatory responses in influenza A virus infection. Julkunen I, Melen K, Nyqvist M, Pirhonen J, Sareneva T, Matikainen S, Vaccine 2001 19 32 S37
26. Understanding the symptoms of the common cold and influenza. Eccles R, Lancet Infect Dis 2005 5 718 725 10.1016/S1473-3099(05)70270-X 16253889
27. Influenza A virus infection kinetics: quantitative data and models. Smith A, Perelson A, Wiley Interdisciplinary Rev: Syst Biol Med 2011 3 429 445 [ http://dx.doi.org/10.1002/WSBM.129 ] 10.1002/wsbm.129
28. A review of mathematical models of influenza A infections within a host or cell culture: lessons learned and challenges ahead. Beauchemin C, Handel A, BMC Public Health 2011 11 Suppl 1 7 10.1186/1471-2458-11-S1-S7
29. Attenuated influenza produced by experimental intranasal inoculation. Little JW, Gordon RD, Hall WJ, Roth FK, J Med Virol 1979 3 3 177 188 10.1002/jmv.1890030303 479857
30. Estimated epidemiologic parameters and morbidity associated with pandemic H1N1 influenza. Tuite A, Greer A, Whelan M, Winter A, Lee B, Yan P, Wu J, Moghadas S, Buckeridge D, Pourbohloul B, Fisman DN, Can Med Assoc J 2010 182 2 131 136 10.1503/cmaj.091807
31. Impaired immune responses in the lungs of aged mice following influenza infection. Toapanta F, Ross TM, Respir Res 2009 10 112 131 10.1186/1465-9921-10-112 19922665
32. 2005-2009 U.S. Synthetic Population Ver. 2. RTI International. Wheaton W, 2012 [ https://www.epimodels.org/midas/Rpubsyntdata1.do ]
33. Attribute assignment to a synthetic population in support of agent-based disease modeling. Cajka J, Cooley P, Wheaton W, Methods Rep (RTI Press) 2010 19 1009 1 22577617
34. Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza. Hayden F, Treanor J, Betts RF, Lobo M, Esinhart JD, Hussey EK, J Am Med Ass 1996 275 295 299 10.1001/jama.1996.03530280047035
35. Efficacy and tolerability of the oral neuraminidase inhibitor peramivir in experimental human influenza: randomized, controlled trials for prophylaxis and treatment. Barroso L, Treanor J, Gubareva L, Hayden F, Antivir Ther 2005 10 901 910 16430195
36. Respiratory nitric oxide levels in experimental human influenza. Murphy A, Platts-Mills T, Lobo M, Hayden F, Chest 1998 114 452 456 10.1378/chest.114.2.452 9726729
37. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Carrat F, Vergu E, Ferguson N, Lemaitre M, Cauchemex S, Leach S, Valleron A, Am J Epidemiol 2008 167 775 785 10.1093/aje/kwm375 18230677
38. Kinetics of influenza A virus infection in humans. Baccam P, Beauchemin C, Macken C, Hayden F, Perelson A, J Virol 2006 80 7590 7599 10.1128/JVI.01623-05 16840338
39. A question of self-preservation: immunopathology in influenza virus infection. La Gruta NL, Kedzierska K, Stambas J, Doherty PC, Immunol Cell Biol 2007 85 2 85 92 10.1038/sj.icb.7100026 17213831
40. Cytokines and fever. Conti B, Taberean I, Andrei C, Bartfai T, Front Biosci 2004 9 1433 1449 10.2741/1341 14977558
41. Descotes J, Vial T, Flu-like syndrome and cytokines. Cytokines in Human Health New Jersey: Humana Press 2007
42. Psychological stress, cytokine production, and severity of upper respiratory illness. Cohen S, Doyle WJ, Skoner DP, Psychosom Med 1999 61 2 175 180 10.1097/00006842-199903000-00009 10204970
43. Evidence for cytokine mediation of disease expression in adults experimentally infected with influenza A virus. Skoner DP, Gentile DA, Patel A, Doyle WJ, J Infect Dis 1999 180 10 14 10.1086/314823 10353855
44. Increased interleukin-6 levels in nasal lavage samples following experimental influenza A virus infection. Gentile D, Doyle W, Whiteside T, Fireman P, Hayden FG, Skoner D, Clin Diagn Lab Immunol 1998 5 5 604 608 9729523
45. Equations of state calculations by fast computing machines. Metropolis N, Rosenbluth A, Rosenbluth M, Teller A, Teller E, J Chem Phys 1953 21 1087 1092 10.1063/1.1699114
46. Monte Carlo sampling methods using Markov chains and their applications. Hastings W, Biometrika 1970 57 97 109 10.1093/biomet/57.1.97
47. Gammerman D, Lopas H, Markov chain Monte Carlo stochastic simulation for Bayesian inference Boca Raton, FL: Chapman & Hall/CRC, Taylor and Francis Group 2006
48. Parallel tempering: theory, applictions and new perspectives. Earl D, Deem M, Phys Chem Chem Phys 2005 7 3910 3916 10.1039/b509983h 19810318
49. Statistical mechanical approaches to models with many poorly known parameters. Brown K, Sethna J, Phys Rev E 2003 68 021904
50. Universally sloppy parameter sensitivities in systems biology models. Gutenkunst R, Waterfall J, Casey F, Brown K, Myers C, Sethna J, PLoS Comput Biol 2007 3 189 10.1371/journal.pcbi.0030189
51. Simulation and prediction of the adaptive immune response to Influenza A virus infection. Lee H, Topham D, Park S, Hollenbaugh J, Treanor J, Mosmann T, Jin X, Ward B, Miao H, Holden-Wiltse J, Perelson A, Zand M, Wu H, J Virol 2009 83 7151 7165 10.1128/JVI.00098-09 19439465
52. Temporal dynamics of host molecular responses to differentiate symptomatic and asymptomatic influenza A infection. Huang Y, Zaas A, Rao A, Dobigeon N, Woolf P, Velman T, ien NO, McClain M, Varkey J, Nicholson B, Carin L, Kingsmore S, Woods C, Ginsburg G, III AH, PLoS Genet 2011 7 100234
53. Population modeling of influenza A/H1N1 virus kinetics and symptom dynamics. Canini L, Carrat F, J Virol 2011 85 2764 2770 10.1128/JVI.01318-10 21191031
54. Shedding and transmission of novel influenza virus A/H1N1 infection in households-Germany, 2009. Seuss T, Buchholz U, Dupke S, Grunow R, an der Heiden M, Heider A, Biere B, Schweiger B, Haas W, Krause G, Am J Epidemiol 2009 11 1157 64
55. Novel influenza A (H1N1) outbreak at the US Air Force Academy: epidemiology and viral shedding duration. Witkop C, Duffy M, Macias E, Gibbons T, Escobar J, Burwell K, Knight K, Am J Prev Med 2010 38 2 121 126 10.1016/j.amepre.2009.10.005 19850440
56. Incubation periods of acute respiratory viral infections: a systematic review. Lessler J, Reich N, Brookmeyer R, Perl T, Nelson K, Cummings D, Lancet Infect Dis 2009 9 5 291 300 10.1016/S1473-3099(09)70069-6 19393959
57. Viral shedding and clinical illness in naturally acquired Influenza A virus infections. Lau L, Cowling B, Chan KH, Lau E, Lipsitch M, Cheng C, Houck P, Uyeki T, Peiris J, Leung G, J Infect Dis 2010 201 1509 1516 10.1086/652241 20377412
58. Onset and duration of symptoms and timing of disease transmission of 2009 influenza A (H1N1) in an outbreak in Fukuoka, Japan, June 2009. Yamagishi T, Matsui T, Nakamura N, Oyama T, Taniguchi K, Aoki T, Hirakawa K, Okabe N, Jpn J Infect Dis 2010 63 5 327 31 20858998
59. Outbreak of 2009 pandemic influenza A (H1N1) at a New York City school. Lessler J, Reich N, Cummings D, N Engl J Med 2009 361 27 2628 2636 10.1056/NEJMoa0906089 20042754
60. Understanding the immune response to seasonal influenza vaccination in older adults: a systems biology approach. Lambert ND, Ovsyannikova IG, Pankratz VS, Jacobson RM, Poland GA, Expert Rev Vaccines 2012 11 985 994 10.1586/erv.12.61 23002979
61. Observations on mortality during the 1918 influenza pandemic. Luk J, Gross P, Thompson WW, Clin Infect Dis 2001 33 8 1375 1378 10.1086/322662 11565078
62. Mortality from influenza, 1957-1958 and 1959-1960. Dauer C, Serfling R, Am Rev Respir Dis 1961 83 Suppl 2 15 26
63. Influenza: old and new threats. Palese P, Nat Med 2004 10 82 S87 10.1038/nm1141 15577936
64. Protective immunity and susceptibility to infectious diseases: lessons from the 1918 influenza pandemic. Ahmed R, Oldstone MB, Palese P, Nat Immunol 2007 8 11 1188 1193 10.1038/ni1530 17952044
65. Howden LM, Meyer JA, Age and sex composition: 2010:2010 census briefs Washington, DC: U.S. Census Bureau 2011 Available at: [ http://www.census.gov/prod/cen2010/briefs/c2010br-03.pdf ]
66. American fact finder. Bureau, USCensus, Website 2013 [ http://www.census.gov/prod/cen2010/briefs/c2010br-03.pdf ]
67. Mixing patterns between age groups in social networks. Del Valle SY, Hyman J, Hethcote HW, Eubank SG, Social Netw 2007 29 4 539 554 10.1016/j.socnet.2007.04.005
68. Inferring the structure of social contacts from demographic data in the analysis of infectious diseases spread. Fumanelli L, Ajelli M, Manfredi P, Vespignani A, Merler S, PLoS Comput Biol 2012 8 9 1002673 10.1371/journal.pcbi.1002673 23028275
69. Social contacts and mixing patterns relevant to the spread of infectious diseases. Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, Massari M, Salmaso S, Tomba GS, Wallinga J, Heijne J, Sadkowska-Todys M, Rosinka M, Edmunds WJ, PLoS Med 2008 5 3 74 10.1371/journal.pmed.0050074 18366252
70. Does influenza transmission occur from asymptomatic infection or prior to symptom onset? Patrozou E, Mermel LA, Public Health Rep 2009 124 2 193 19320359
71. Neuraminidase inhibitor resistance in influenza: assessing the danger of its generation and spread. Handel A, Longini IM Jr, Antia R, PLoS Comput Biol 2007 3 240 10.1371/journal.pcbi.0030240 18069885
72. An in-host model of acute infection: Measles as a case study. Heffernan J, Keeling MJ, Theor Popul Biol 2008 73 134 147 10.1016/j.tpb.2007.10.003 18048070
73. Defense mechanisms against Influenza virus infection in the respiratory tract mucosa. Tamura S, Kurata T, Jpn J Infect Dis 2004 57 236 247 15623947
74. Towards a quantitative understanding of the within-host dynamics of influenza A infections. Handel A, Longini IM Jr, Antia R, J R Soc Interface 2010 7 35 47 10.1098/rsif.2009.0067 19474085